Keeping pace with immuno-oncology research breakthroughs and biomarker identification

Keeping pace with immuno-oncology research breakthroughs and biomarker identification

Adrian Benjamin, PhD, Illumina and Kimberly Robasky, PhD, Q2 Solutions, Illumina and Q2 Solutions
Topic: Cancer Genomics

The excitement surrounding immuno-oncology is being driven by results seen in the clinic. New treatments can potentially be made more efficacious using NGS technology that would accelerate biomarker identification and bring down costs for research subject screening and safety monitoring. Among these technologies is RNA-Seq, a flexible sequencing assay that enables multiple applications with one assay from a single sample. In this webinar, we'll summarize the clinical relevance of RNA-Seq, when and how to use expression profiling economically, some common challenges and associated remedies.

Key learning objectives
 
Learn how legacy RNA-Seq datasets can be revisited for new insights to keep pace with today’s rapid advance of therapeutic breakthroughs
Learn how RNA-Seq provides high-throughput, comprehensive, direct measurement of functionally relevant molecular processes
Learn more about key applications for RNA-Seq in immuno-oncology


There are no related events.